Company profile for Nyxoah

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the world’s most common sleep disordered breathing condition that is associat...
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the world’s most common sleep disordered breathing condition that is associated with increased mortality risk* and comorbidities including cardiovascular diseases, depression and stroke.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Rue Edouard Belin 12 1435 Mont-Saint-Guibert
Telephone
Telephone
+32 10 45 90 75
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/04/30/3285476/0/en/nyxoah-to-participate-in-the-bank-of-america-2026-healthcare-conference.html

GLOBENEWSWIRE
30 Apr 2026

https://www.globenewswire.com/news-release/2026/04/28/3283163/0/en/nyxoah-to-release-first-quarter-2026-financial-results-on-may-12-2026.html

GLOBENEWSWIRE
28 Apr 2026
Publication of Transparency Notifications
Publication of Transparency Notifications

20 Mar 2026

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2026/03/20/3259972/0/en/Publication-relating-to-transparency-notifications.html

GLOBENEWSWIRE
20 Mar 2026

https://www.globenewswire.com/news-release/2026/03/19/3259442/0/en/Nyxoah-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-and-Operating-Results.html

GLOBENEWSWIRE
19 Mar 2026
Publication of Transparency Notification
Publication of Transparency Notification

13 Mar 2026

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2026/03/13/3255821/0/en/Publication-relating-to-transparency-notification.html

GLOBENEWSWIRE
13 Mar 2026

https://www.globenewswire.com/news-release/2026/03/11/3254182/0/en/Nyxoah-to-Participate-in-the-Oppenheimer-36th-Annual-Healthcare-MedTech-Services-Conference.html

GLOBENEWSWIRE
11 Mar 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty